Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Buprenorphine/naloxone sublingual - Benuvia Therapeutics

Next Previous
X
Search
Drug Profile

Buprenorphine/naloxone sublingual - Benuvia Therapeutics

Alternative Names: Buprenorphine + naloxone - Benuvia Therapeutics; Buprenorphine/naloxone - Benuvia Therapeutics; Buprenorphine/naloxone sublingual spray - INSYS Therapeutics

Latest Information Update: 30 Oct 2021

Price :

$50 *

Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator INSYS Therapeutics, Inc
  • Class Antidotes; Benzofurans; Cyclopropanes; Drug withdrawal therapies; Isoquinolines; Morphinans; Opioid analgesics; Small molecules
  • Mechanism of Action Nociceptin receptor agonists; Opioid delta receptor antagonists; Opioid kappa receptor antagonists; Opioid mu receptor agonists; Opioid mu receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No
  • Available For Licensing Yes

Highest Development Phases

  • Phase II Opioid-related disorders

Most Recent Events

  • 18 Aug 2021 Chemical structure information added
  • 23 Mar 2021 Phase II development in Opioid-related disorders is ongoing in USA (Sublingual) (Benuvia Therapeutics pipeline, March 2021)
  • 23 Mar 2021 Buprenorphine/naloxone sublingual spray - Benuvia Therapeutics is available for licensing as of 23 Mar 2021. https://www.benuvia.com/

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top